VALGEN MEDTECH
Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.
VALGEN MEDTECH
Industry:
Health Care Health Diagnostics Hospital
Founded:
2015-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.valgenmed.com
Status:
Closed
Total Funding:
188 M USD
Current Employees Featured
Investors List
China Life Healthcare Fund
China Life Healthcare Fund investment in Series B - Valgen Medtech
Sequoia Capital China
Sequoia Capital China investment in Series B - Valgen Medtech
Lake Bleu Capital
Lake Bleu Capital investment in Series B - Valgen Medtech
Ascendum Capital
Ascendum Capital investment in Series B - Valgen Medtech
Venus MedTech
Venus MedTech investment in Series B - Valgen Medtech
China Life Insurance
China Life Insurance investment in Series B - Valgen Medtech
DCP Capital
DCP Capital investment in Series B - Valgen Medtech
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Valgen Medtech
Official Site Inspections
http://www.valgenmed.com
- Host name: 139.224.130.107
- IP address: 139.224.130.107
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Valgen Medtech"
Home-Valgenmed
Valgen Medtech is headquartered in Hangzhou High-Tech Zone (Binjiang) Hangzhou and established an R&D center has been accredited as a national and provincial (Zhejiang) …See details»
Valgenmed
DragonFly TM 具备完全自主知识产权。 截至2023年09月，围绕产品的基本原理、核心方案、关键创新点，共计申请国内外专利150余项，其中国内外发明专利95项，PCT申请28项，已授权专 …See details»
Company Overview-Valgenmed
Hangzhou Valgen Medtech Co., Ltd. ( Valgen Medtech) is dedicated to the interventional treatment of structural heart diseases. Founded in 2015 in Hangzhou, Valgen Medtech applied for more than 500 patents worldwide by …See details»
Valgen Medtech - Crunchbase Company Profile
Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.See details»
Valgen Medtech - VentureRadar
"ValgenMed is committed to providing systematic solutions for diseases such as mitral regurgitation and tricuspid regurgitation. ValgenMed has developed MitralStitch, the first …See details»
Valgen Medtech 2025 Company Profile: Valuation, …
Valgen Medtech General Information Description. Researcher and developer of minimally invasive medical devices intended to serve the medical field. The company focuses on technological innovation and product development for …See details»
Valgen Medtech Co., Ltd. Overview | SignalHire Company Profile
Rooms 101-108, 1F&2F, Building C, 58 Qiuyi Road, Changhe Street, Binjiang District, Hangzhou, Zhejiang, 310051, China, CNSee details»
Valgen Medtech - Products, Competitors, Financials, Employees ...
Hangzhou Valgen’s DRAGONFLY-DMR Pivotal Trial Results Presented. Jun 19, 2023. Hangzhou Valgen’s DRAGONFLY-DMR Pivotal Trial Results Presented June 19, 2023—China-based …See details»
Hangzhou Valgen Medtech Co., Ltd. - Drug pipelines, Patents, …
Explore Hangzhou Valgen Medtech Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 10 clinical trials, 1 news.See details»
Hangzhou Valgen Medtech Co., Ltd. - cnverify.com
Employees: 100-200 Detail (43.19% of Chinese foreign trade enterprises have 0 employees) Registered capital: 600,000,000 RMB Detail Paid in capitalSee details»
Valgen Medtech Announces the Completion of its Round B …
May 6, 2021 Valgen Medtech (Hangzhou, China; May 6, 2021) Hangzhou Valgen Medtech Co., Ltd. (Valgen Medtech), a subsidiary of Dinova Medtech Group (Dinova Medtech), announces …See details»
Valgen validates series B funding - Global Venturing
May 7, 2021 China-based heart disease therapy developer Valgen Medtech has secured a nine-digit dollar amount in series B funding from investors including corporates Venus Medtech and …See details»
Hangzhou Valgen Medtech Co., Ltd. (杭州德晋医疗科技有限公司)
Launching of the 1st Human Implantation of "DragonRing" – Catheter-based Mitral Annuloplasty Device HANGZHOU, China, Nov. 5, 2022 /PRNewswire/ -- On October 28, 2022, a …See details»
Careers - Valgenmed
If you want to apply for any position, please submit your application to [email protected]. Join us. Eager to take on a challenge and develop with Valgen Medtech? Join us to realize …See details»
德晋医疗-动脉网 - vbdata.cn
Aug 28, 2015 杭州德晋医疗科技有限公司（下称：德晋医疗）专注于结构性心脏病介入治疗领域。2015 年成立于杭州，至 2023 年底公司已在全球累计申请专利500余项，其中150余项已授 …See details»
会议速递｜德晋医疗两款创新产品重磅亮相2025俄罗斯XVI MICHS …
Feb 15, 2025 手术在中国医学科学院阜外医院潘湘斌教授团队王首正教授助力下，与俄罗斯卫生部国家心脏病医学研究中心（Federal State Budgetary Organization National Cardiology …See details»
Solutions - Valgenmed
Puncture sheath: Increased hardness, greater supporting force; Better anti-bending performance, sheathing canal less susceptible to deformation; Greater torsional strength, better axial …See details»
Hangzhou Valgen Medtech Co. Ltd. - Patsnap
Nov 23, 2022 Discovery Company profile page for Hangzhou Valgen Medtech Co. Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Patient Experience-Valgenmed
The transcatheter mitral valve edge-to-edge repair procedure is the most mature and reliable mitral valve intervention technique by far; this off-pump procedure requires neither …See details»
News and Information - Valgenmed
第35届经导管心血管会议（TCT.2023）在美国旧金山拉开帷幕，会议主旨为介入心脏病专家和业内专业人士分享改善患者治疗质量的最新技术成果，浙江大学医学院附属第二医院王建安教授 …See details»